Quest Diagnostics Live Stock Price Today, Share Analysis and Chart

Name: Quest Diagnostics, Inc.: Is Infosys Ltd. worth buying?
Item: Quest Diagnostics, Inc.
Rating: 2.178680625
Author: Trendlyne DVM scores

Mid-range Performer

about

Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 97% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing ...

198.61 -0.33 (-0.17%)

26.34% Gain from 52W Low

792.4K

XNYS Volume

XNYS 17 Mar, 2026 5:30 PM (EDT)

Dividend

Quest Diagnostics has an upcoming dividend of $0.86 per share due on 06 Apr 2026 See details

Medium Financial Strength

38.9 / 100

Mid Valuation

36.7 / 100

Technically Neutral

59.9 / 100

Mid-range Performer These stocks have average quality, financial and technical momentum, indicating a mid range performer View Similar Embed DVM

219

1Yr Price target upside is 10%

16 analysts

Quest Diagnostics Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Quest Diagnostics Live Stock Price Today, Share Analysis and Chart

Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 97% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing ...

26.34% Gain from 52W Low

SWOT Analysis

Quest Diagnostics Live Price Chart